1. 独立行政法人 医薬品医療機器総合機,新医薬品の承認品目一覧. https://www.pmda.go.jp/review- services/drug-reviews/review-information/p-drugs/0010.html 2021年1月7日 閲覧.
2. Jenkins FJ, Van Houten B, Bovbjerg DH. Effects on DNA damage and/or repair processes as biological mechanisms linking psychological stress to cancer risk. J Appl Biobehav Res. 2014;19:3–23.
3. Simonton OC, Matthews-Simonton S. Cancer and stress counselling the cancer patient. Med J Aust. 1981;1(13):682–3.
4. National Center for Complementary and Integrative Health: https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name 2021年1月7日 閲覧.
5. 日本補完代替医療学会. がんの補完代替医療ガイドブック 第3版.
6. Ozkaraman A, Dügüm Ö, Yılmaz HÖ, Yesilbalkan ÖU. The effect of lavender on anxiety and sleep quality in patients treated with chemotherapy. Clin J Oncol Nurs. 2018;22(2):203–10.
7. 藤田小矢香, 井上千晶, 秦幸吉. 妊娠期の母親学級における短期アロマテラピー前後の妊婦の体温・唾液アミラーゼ値・抗酸化力の変化. 島根医学. 2018;38–3:49–53.
8. ほづみ本橋. 酸化ストレス応答転写因子Nrf2による代謝制御と細胞増殖. 生化学. 2014;86(2):269–73.
9. 荒川 和彦 鳥越 一宏 葛巻 直子 鈴木 勉 成田 年. 抗がん剤による末梢神経障害の特徴とその作用機序. 日本緩和医療薬学雑誌. 2011;4:1–13.
10. Kari E, Teppo HR, Haapasaari KM, Kuusisto MEL, Lemma A, Karihtala P, et al. Nuclear factor erythroid 2- related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP. J Clin Pathol. 2019;72:316–21.
11. Kandoth C, Mclellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333–9.
12. Kitamura H, Motohashi H. NRF2 addiction in cancer cells. Cancer Sci. 2018;109:900–11.
13. Yi X, Zhao Y, Xue LI, Zhang J, Qiao Y, Jin Q, et al. Expression of Keap1 and Nrf2 in diffuse large B ‑ cell lymphoma and its clinical significance. Exp Ther Med. 2018;16:573–8.
14. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 2012;103:760–6.
15. Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, Leboeuf SE, et al. Keap1 loss promotes Kras- driven lung cancer and results in dependence on glutaminolysis. Nat Med. 2017;23:1362–8.
16. Rushworth SA, Zaitseva L, Murray MY, Shah NM, Bowles KM, MacEwan DJ. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-kappaB and underlies its chemo-resistance. Blood. 2012;120:5188–98.
17. Meijerman I, Beijnen JH, Schellens JHM. Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer. Cancer Treat Rev. 2008;34(6):505–20.
18. Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, et al. Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer. 2009;15:3423–33.
19. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, et al. Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth. Cancer Res. 2008;68(5):1303–10.
20. 田中喜秀,
21. 田慎一. ストレスと疲労のバイオマーカー. 日薬理誌(Folia Pharmacol Jpn). 2011;137:2–5.
22.
23. 田慎一. 唾液ストレス計測バイオチップ技術一滴唾液ストレス計測用バイオチップの研究開発.臨床検査. 2015;59:429–34.
24. 山口昌樹. 唾液マーカーでストレスを測る. 日薬理誌. 2007;129:80–4.
25. Tamura S, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis. 2004;57:236–47.
26. Silvey KJ, Hutchings AB, Vajdy M, Petzke M, Neutra MR, Hutchings AMYB, et al. Role of Immunoglobulin A in Protection against Reovirus Entry into Murine Peyer’s Patches. J Virol. 2001;75 (22):10870–9.
27. Deinzer R, Kleineidam C, Stiller-Winkler R, Idel H, Bachg D. Prolonged reduction of salivary immunoglobulin A (sIgA) after a major academic exam. Int J Psychophysiol. 2000;37:219–32.
28. Bruehlman-Senecal E, Ayduk Ã, John OP. Taking the long view: Implications of individual differences in temporal distancing for affect, stress reactivity, and well-being. J Pers Soc Psychol. 2016;111:610–35.
29. Fujihara S, Yogo M. Time series changes in salivary secretory immunoglobulin A to acute stress. Japanese J Physiol Psychol Psychophysiol. 2011;29:193–203.
30. 日本緩和医療学会 がん補完代替医療ガイドライン 第1版https://www.jspm.ne.jp/guidelines/cam/cam01.pdf 2021年1月7日 閲覧.
31. 日本緩和医療学会. Clinical Evidence for Complementary and Alternative Therapies in Cancer Patients. 東京: 金原出版; 2016.
32. Takagi C, Nakagawa S, Hirata N, Ohta S, Shimoeda S. Evaluating the effect of aromatherapy on a stress marker in healthy subjects. Journal of Pharmaceutical Health Care and Sciences; 2019;5(18):1–7.
33. Chen P-J, Chou C-C, Yang L, Tsai Y-L, Chang Y-C, Liaw J-J. Effects of Aromatherapy Massage on Pregnant Women’s Stress and Immune Function: A Longitudinal, Prospective, Randomized Controlled Trial. J Altern Complement Med. 2017;00:acm.2016.0426.
34. 藤原桜, 尾﨑雅子, 中村由果理, 高野奈央, 高松邦彦, 破魔幸枝, et al. 子👉て中の母親のストレス にアロマセラピーが及ぼす影響-唾液アミラーゼ活性・日本語版 POMS2短縮版からの検証-. 神戸常磐大学紀要. 2020;13:83–92.
35. 阪上未紀, 林紀行, 松本めぐみ, 足立由香, 前田和久, 伊藤壽記. 大規模災害の後遺障害に対する統合医療的アプローチ‐アロマセラピーからの評価‐. J Japanese Soc Aromather. 2014;13(1):12–6.
36. 山口はる奈. 精神科外来における芳香浴法の効果-患者および家族に対するアンケート調査を用 いて . 日本精神科看護学術集会誌. 2013;56(1):326–7.
37. Phillips AC, Carroll D, Evans P, Bosch JA, Clow A, Hucklebridge F, et al. Stressful life events are associated with low secretion rates of immunoglobulin A in saliva in the middle aged and elderly. Brain Behav Immun. 2006;20:191–7.
38. 佐藤勝祥, 増子孝則, 折橋毅典, 萩野顕彦, 小原嘉昭, 盧尚猛建, et al. 反芻動物のストレス関連ホルモン分泌における下垂体前葉- 後葉連関. 畜産の研究. 2012;669:889–95.
39. 新島旭. アロマセラピーの生理学的基礎 Physiological background of aromatherapy. Japanese Soc Aromatheray. 2007;6:13–21.
40. 長町千里. アロマセラピーの臨床応用. 日本心臓リハビリテーション学会. 2010;15(2):239–41.
41. 山田律爾. 血中カテコールアミン. 日本臨床. 1992;50(4):773–7.
42. Frank H, Angela C, Phil E. The relationship between salivary secretory immunoglobulin A and cortisol: neuroendocrine response to awakening and the diurnal cycle. Int J Psychophysiol. 1998;31:69–76.
43. Kuriyama H, Watanabe S, Nakaya T, Shigemori I, Kita M, Yoshida N, et al. Immunological and psychological benefits of aromatherapy massage. Evidence-based Complement Altern Med. 2005;2:179–84.
44. 樋口裕二, 内富庸介. がん医療・緩和医療におけるうつ病の実態と精神科医による介入のあり方. Depress Strateg. 2015;5–3:5–9.
45. 藤原桂子, 神田清子, 京田亜由美, 本多昌子, 菊池沙織, 今井洋子. Oxaliplatin による末梢神経障害「しびれを経験する 大腸がん患者の精神的ストレス内容と対処. 日本がん看護学会誌. 2016;30(2):63–70.
46. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The Prevalence of Psychiatric Disorders Among Cancer Patients. JAMA. 1983;249(6):751–7757.
47. 日本がんサポーティブ学会. がん薬物療法に伴う末梢神経障害マネジメントの手引き 2017年版.東京: 金原出版; 2017.
48. 早坂正敏, 葉山達也, 中馬真幸, 藏内恭子, 今井徹, 中山敏光, et al. 進行大腸がんに対するFOLFOX4療法2週ごと施行逸脱の要因調査. 日病薬誌. 2009;45(10):1329–33.
49. Katayama H, Mishima E, Sasaki T, Ban A, Yokoyama S, Katsuragawa K, et al. CapeOX療法の完遂率に影響を与える要因の調査および適
50. な介入方法を目指した多施設共同研究. 日本病院薬剤師会雑誌. 2019;55(1):47–52.
51. Zajączkowska R, Kocot-Kępska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci. 2019;20(6):1–29.
52. Rushmore TH, Morton MR, Pickett B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991;266:11632–9.
53. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD ( P ) H : quinone oxidoreductase 1 gene. Proc Natl Acad Sci USA. 1996;93:14960–5.
54. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13(1):76–86.
55. Kang M, Kobayashi A, Wakabayashi N, Kim S, Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA,. 2004;101:2046–51.
56. 原宏和. 酸化ストレスに対して神経細胞保護作用を有する化合物の作用機序の解明. YAKUGAKUZASSHI. 2007;127(8):1199–205.
57. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2 / Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements. Biochem Biophys Res Commun. 1997;322:313–22.
58. Yang Y, Luo L, Cai X, Fang Y, Wang J, Chen G, et al. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function. Free Radic Biol Med. 2018;120:13–24.
59. Kim S, Choo J, Ju S. The effect of aroma stimulation during isotonic exercise on the rating of perceived exertion and blood fatigue factors of athletes with patellofemoral pain syndrome. 2018;231–3.
60. Lin T, Wang S, Huang C, Lai Y. Anti-Fatigue, Antioxidation, and Anti-Inflammatory Effects of Eucalyptus Oil Aromatherapy in Swimming-Exercised Rats. Chinese J Pgysioligy. 2018;1–9.
61. 原島沙季, 菊地裕絵, 吉内一浩. ストレスの生理学的測定法. J Otolaryngol Head Neck Surg. 2015;31(3):279–82.
62. 後藤幸生. 心身自律神経バランス学. 東京: 真興交易医書出版部; 2011.
63. 堀輝, 香月あすか, 菅健太郎, 吉村玲児. 客観的なストレス評価方法について. 日本職業・災害医学会会誌. 2018;66(5):330–4.
64. Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med. 2004;18(2):87–92.
65. Mayer FB, Santos IS, Silveira PSP, Helena M, Lopes I, Regina A, et al. Factors associated to depression and anxiety in medical students : a multicenter study. BMC Med Educ. BMC Medical Education; 2016;16(282):1–9.
66. Perciavalle Valentina, Blandini M, Fecarotta P, Buscemi A, Corrado D Di, Bertolo L, et al. The role of deep breathing on stress. Neurol Sci. 2016;38:451–8.
67. Sugiyama K, Isogai K, Horisawa S, Toyama A, Satoh H. Comparative Study of the Cellular Pharmacodynamics of Tacrolimus in Renal Transplant Recipients Treated With and Without Basiliximab. Cell Transplant. 2012;21:565–70.
68. Ohnuma T, Sakamoto K, Shinoda A, Takagi C, Ohno S, Nishiyama T, et al. Procyanidins from Cinnamomi Cortex promote proteasome-independent degradation of nuclear Nrf2 through phosphorylation of insulin-like growth factor-1 receptor in A549 cells. Arch Biochem Biophys. 2017;635:66–73.
69. BIO GPS, NFE2L2 (nuclear factor, erythroid 2 like 2) http://biogps.org/#goto=genereport&id=4780 2021年1月7日 閲覧.
70. 伊東健. Nrf2酸化ストレス応答系による病態制御. 生化学. 2009;81(6):447–55.
71. 秋吉久美代. リラックス効果に影響する精油成分と嗜好の関係. 奈良看護紀要. 2015;11:77–84.
72. 秋吉久美代. ニオイの好き嫌いの程度がヒトに及ぼす リラックス効果について. 奈良看護紀要. 2013;9:23–31.
73. 由留木裕子, 鈴木俊明. ラベンダーの香りと神経機能に関する文献的研究. 関西医療大学紀要.2012;6:109–15.
74. 森恵莉. 嗅覚の基礎と臨床. 日本耳鼻咽喉科学会会報. 2020;123(7):557–62.
75. Rushworth SA, MacEwan DJ. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood. 2008;111:3793–801.
76. 国 立 が ん 研 究 セ ン タ ー が ん 情 報 サ ー ビ ス , 悪 性 リ ン パ 腫 : https://ganjoho.jp/public/cancer/ML/treatment.html 2021年1月7日 閲覧.
77. Maria A, Pasini F, Ferrari M, Zambon G, Cominacini L. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild – moderate ex-smoker COPD patients with persistent oxidative stress. Int Joural COPD. 2016;1733–43.